132 related articles for article (PubMed ID: 1335080)
1. Para-substituted Phe3 deltorphin analogues: enhanced selectivity of halogenated derivatives for delta opioid receptor sites.
Salvadori S; Bianchi C; Lazarus LH; Scaranari V; Attila M; Tomatis R
J Med Chem; 1992 Dec; 35(25):4651-7. PubMed ID: 1335080
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of 1-aminocycloalkane-1-carboxylic acid-substituted deltorphin analogues: unique delta and mu opioid activity in modified peptides.
Breveglieri A; Guerrini R; Salvadori S; Bianchi C; Bryant SD; Attila M; Lazarus LH
J Med Chem; 1996 Feb; 39(3):773-80. PubMed ID: 8576920
[TBL] [Abstract][Full Text] [Related]
3. Phe3-substituted analogues of deltorphin C. Spatial conformation and topography of the aromatic ring in peptide recognition by delta opioid receptors.
Salvadori S; Bryant SD; Bianchi C; Balboni G; Scaranari V; Attila M; Lazarus LH
J Med Chem; 1993 Nov; 36(24):3748-56. PubMed ID: 8254604
[TBL] [Abstract][Full Text] [Related]
4. Conformationally restricted deltorphin analogues.
Schiller PW; Weltrowska G; Nguyen TM; Wilkes BC; Chung NN; Lemieux C
J Med Chem; 1992 Oct; 35(21):3956-61. PubMed ID: 1331451
[TBL] [Abstract][Full Text] [Related]
5. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity.
Heyl DL; Schmitter SJ; Bouzit H; Johnson TW; Hepp AM; Kurtz KR; Mousigian C
Int J Pept Protein Res; 1994 Nov; 44(5):420-6. PubMed ID: 7896499
[TBL] [Abstract][Full Text] [Related]
6. Helix-inducing alpha-aminoisobutyric acid in opioid mimetic deltorphin C analogues.
Bryant SD; Guerrini R; Salvadori S; Bianchi C; Tomatis R; Attila M; Lazarus LH
J Med Chem; 1997 Aug; 40(16):2579-87. PubMed ID: 9258365
[TBL] [Abstract][Full Text] [Related]
7. Bioactivity of new mu and delta opioid peptides.
Capasso A
Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
[TBL] [Abstract][Full Text] [Related]
8. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
[TBL] [Abstract][Full Text] [Related]
9. Opioid receptor selectivity reversal in deltorphin tetrapeptide analogues.
Lazarus LH; Salvadori S; Tomatis R; Wilson WE
Biochem Biophys Res Commun; 1991 Jul; 178(1):110-5. PubMed ID: 1648906
[TBL] [Abstract][Full Text] [Related]
10. Development of a model for the delta opioid receptor pharmacophore. 2. Conformationally restricted Phe3 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
Mosberg HI; Omnaas JR; Lomize A; Heyl DL; Nordan I; Mousigian C; Davis P; Porreca F
J Med Chem; 1994 Dec; 37(25):4384-91. PubMed ID: 7996550
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
12. Single diastereomeric desaminotyrosylalanyl tetra- and heptapeptides with opioid antagonistic activity.
Balboni G; Salvadori S; D'Angeli F; Marchetti P; Lazarus LH; Bryant SD; Bianchi C
Int J Pept Protein Res; 1995 Feb; 45(2):187-93. PubMed ID: 7782167
[TBL] [Abstract][Full Text] [Related]
13. Opioid deltorphin C analogues containing cis- or trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues.
Marastoni M; Guerrini R; Balboni G; Salvadori S; Fantin G; Fogagnolo M; Lazarus LH; Tomatis R
Arzneimittelforschung; 1999 Jan; 49(1):6-12. PubMed ID: 10028372
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of deltorphin analogues.
Salvadori S; Marastoni M; Balboni G; Borea PA; Morari M; Tomatis R
J Med Chem; 1991 May; 34(5):1656-61. PubMed ID: 1851843
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological properties of beta-MePhe3 analogues of deltorphin I and dermenkephalin: influence of biased chi 1 Phe3 residues on peptide recognition for delta-opioid receptors.
Misicka A; Cavagnero S; Horvath R; Davis P; Porreca F; Yamamura HI; Hruby VJ
J Pept Res; 1997 Jul; 50(1):48-54. PubMed ID: 9273887
[TBL] [Abstract][Full Text] [Related]
16. Stereospecificity of amino acid side chains in deltorphin defines binding to opioid receptors.
Lazarus LH; Salvadori S; Balboni G; Tomatis R; Wilson WE
J Med Chem; 1992 Apr; 35(7):1222-7. PubMed ID: 1313878
[TBL] [Abstract][Full Text] [Related]
17. Function of negative charge in the "address domain" of deltorphins.
Lazarus LH; Salvadori S; Santagada V; Tomatis R; Wilson WE
J Med Chem; 1991 Apr; 34(4):1350-5. PubMed ID: 1849997
[TBL] [Abstract][Full Text] [Related]
18. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
Sagan S; Corbett AD; Amiche M; Delfour A; Nicolas P; Kosterlitz HW
Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
[TBL] [Abstract][Full Text] [Related]
19. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor.
Charpentier S; Sagan S; Delfour A; Nicolas P
Biochem Biophys Res Commun; 1991 Sep; 179(3):1161-8. PubMed ID: 1656944
[TBL] [Abstract][Full Text] [Related]
20. Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.
Salvadori S; Attila M; Balboni G; Bianchi C; Bryant SD; Crescenzi O; Guerrini R; Picone D; Tancredi T; Temussi PA
Mol Med; 1995 Sep; 1(6):678-89. PubMed ID: 8529134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
